A Comparative Clinical Study to Evaluate the Effect of Trivrutta Churna Nitya Virechana with Anupana as Sharkara and Go-Ghrita in Yakruta Vikara (Liver Disorders) with special reference to Abnormal Liver Function Tests (LFTs).
Phase 3
Completed
- Conditions
- Health Condition 1: K70-K77- Diseases of liverHealth Condition 2: K77- Liver disorders in diseases classified elsewhere
- Registration Number
- CTRI/2019/09/021072
- Lead Sponsor
- Dr PATIL JAGDISH PRAKASHRAO
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 90
Inclusion Criteria
Ages of above 18 years and below 65 years
Diagnosed Liver disorder with abnormal LFT
Exclusion Criteria
Known case of hepatitis-B or hepatitis-C
Obstructive Liver Disease.
Advanced liver disease (e.g. ascites, bleeding oesophageal varies and hepatic Encephalopathy, hepatic cancer, cirrhosis of liver).
Subjects with serious illness,e.g.,uncontrolled diabetes, HIV, serious cardiovascular Disease.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To Evaluate the effect of Trivrutta Churna Nitya Virechana in Yakrut Vikara (Liver Diseases) with abnormal liver function test.Timepoint: 21 Days
- Secondary Outcome Measures
Name Time Method To access the efficacy of Sagoghruta Nitya Virechana in the liver disorder.Timepoint: 21 days;To access the efficacy of Sasharkara Nitya Virechana in the liver disorder.Timepoint: 21 Days;To compare the efficacy of Nitya Virechana with Sharkara and Goghruta.Timepoint: 21 Days;To find out the relative early clinical and biological improvement between treatment groupsTimepoint: 21 Days;To measure the incidence of adverse events, adverse drug reactions, safety lab parameters (hematology, biochemistry) and vital during the study.Timepoint: 21 Days